7-21735769-T-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001277115.2(DNAH11):​c.7570T>C​(p.Leu2524Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0606 in 1,613,770 control chromosomes in the GnomAD database, including 6,619 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.12 ( 1799 hom., cov: 33)
Exomes 𝑓: 0.055 ( 4820 hom. )

Consequence

DNAH11
NM_001277115.2 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.995

Publications

12 publications found
Variant links:
Genes affected
DNAH11 (HGNC:2942): (dynein axonemal heavy chain 11) This gene encodes a ciliary outer dynein arm protein and is a member of the dynein heavy chain family. It is a microtubule-dependent motor ATPase and has been reported to be involved in the movement of respiratory cilia. Mutations in this gene have been implicated in causing Kartagener Syndrome (a combination of situs inversus totalis and Primary Ciliary Dyskinesia (PCD), also called Immotile Cilia Syndrome 1 (ICS1)) and male sterility. [provided by RefSeq, Mar 2013]
DNAH11 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 7
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), ClinGen
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.73).
BP6
Variant 7-21735769-T-C is Benign according to our data. Variant chr7-21735769-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 163109.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.995 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.243 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAH11NM_001277115.2 linkc.7570T>C p.Leu2524Leu synonymous_variant Exon 46 of 82 ENST00000409508.8 NP_001264044.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAH11ENST00000409508.8 linkc.7570T>C p.Leu2524Leu synonymous_variant Exon 46 of 82 5 NM_001277115.2 ENSP00000475939.1
DNAH11ENST00000605912.1 linkc.130T>C p.Leu44Leu synonymous_variant Exon 1 of 4 3 ENSP00000476068.1

Frequencies

GnomAD3 genomes
AF:
0.116
AC:
17668
AN:
152052
Hom.:
1791
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.247
Gnomad AMI
AF:
0.0362
Gnomad AMR
AF:
0.181
Gnomad ASJ
AF:
0.0591
Gnomad EAS
AF:
0.204
Gnomad SAS
AF:
0.0665
Gnomad FIN
AF:
0.0402
Gnomad MID
AF:
0.0987
Gnomad NFE
AF:
0.0353
Gnomad OTH
AF:
0.108
GnomAD2 exomes
AF:
0.0973
AC:
24236
AN:
249190
AF XY:
0.0869
show subpopulations
Gnomad AFR exome
AF:
0.250
Gnomad AMR exome
AF:
0.251
Gnomad ASJ exome
AF:
0.0651
Gnomad EAS exome
AF:
0.208
Gnomad FIN exome
AF:
0.0403
Gnomad NFE exome
AF:
0.0355
Gnomad OTH exome
AF:
0.0802
GnomAD4 exome
AF:
0.0548
AC:
80113
AN:
1461600
Hom.:
4820
Cov.:
33
AF XY:
0.0536
AC XY:
39000
AN XY:
727082
show subpopulations
African (AFR)
AF:
0.249
AC:
8345
AN:
33470
American (AMR)
AF:
0.242
AC:
10802
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.0676
AC:
1767
AN:
26132
East Asian (EAS)
AF:
0.232
AC:
9220
AN:
39694
South Asian (SAS)
AF:
0.0576
AC:
4971
AN:
86254
European-Finnish (FIN)
AF:
0.0390
AC:
2081
AN:
53398
Middle Eastern (MID)
AF:
0.0600
AC:
346
AN:
5768
European-Non Finnish (NFE)
AF:
0.0345
AC:
38405
AN:
1111800
Other (OTH)
AF:
0.0692
AC:
4176
AN:
60368
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
3742
7484
11227
14969
18711
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1824
3648
5472
7296
9120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.116
AC:
17707
AN:
152170
Hom.:
1799
Cov.:
33
AF XY:
0.117
AC XY:
8706
AN XY:
74394
show subpopulations
African (AFR)
AF:
0.247
AC:
10244
AN:
41486
American (AMR)
AF:
0.182
AC:
2784
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.0591
AC:
205
AN:
3470
East Asian (EAS)
AF:
0.204
AC:
1054
AN:
5176
South Asian (SAS)
AF:
0.0651
AC:
314
AN:
4820
European-Finnish (FIN)
AF:
0.0402
AC:
426
AN:
10596
Middle Eastern (MID)
AF:
0.0856
AC:
25
AN:
292
European-Non Finnish (NFE)
AF:
0.0352
AC:
2397
AN:
68020
Other (OTH)
AF:
0.106
AC:
225
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
736
1472
2207
2943
3679
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
174
348
522
696
870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0656
Hom.:
3156
Bravo
AF:
0.136
EpiCase
AF:
0.0374
EpiControl
AF:
0.0407

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Feb 21, 2013
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Leu2524Leu in exon 46 of DNAH11: This variant is not expected to have clinical s ignificance because it does not alter an amino acid residue and is not located w ithin the splice consensus sequence. It has been identified in 22.3% (860/3850) of African American chromosomes from a broad population by the NHLBI Exome Seque ncing Project (http://evs.gs.washington.edu/EVS; dbSNP rs2072220). -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Primary ciliary dyskinesia Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Dec 31, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.73
CADD
Benign
1.7
DANN
Benign
0.26
PhyloP100
0.99
PromoterAI
0.0090
Neutral
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2072220; hg19: chr7-21775387; COSMIC: COSV60946294; API